All cancer staging systems seek to identify clinical and pathological features that can predict outcome or guide therapy. In particular, a non-invasive method for the early detection of disseminating disease would be of great interest. We investigated the use of cytokeratin genes expression to detec
Detection of disseminated tumor cells in patients with cervical cancer
✍ Scribed by Cornelia Scheungraber; Bernhard Müller; Christhardt Köhler; Marc Possover; Sabine Leistritz; Achim Schneider; Matthias Dürst
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 133 KB
- Volume
- 128
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The prognosis of cancer patients is largely determined by the occurrence of distant metastases. In patients with primary tumors, this relapse is mainly due to clinically occult micrometastasis present in secondary organs at primary diagnosis but not detectable even with high resolution
## Abstract Adjuvant chemotherapy is not routinely recommended in patients with colorectal cancer stage UICC II. Some of these patients, however, develop recurrent disease. Therefore, valid prognostic criteria are needed to identify high‐risk patients who might benefit from adjuvant therapy. Dissem
The clinical impact of circulating tumor cell (CTC) detection is controversial, mainly due to drawbacks of molecular approaches applied to this field. We sought to determine if the specific identification and counting of circulating tumor cells by cytomorphologic analysis has clinical usefulness. Pe